LP266723-8
Sertindole
Active
Description
Sertindole (brand names: Serdolect and Serlect) is an atypical antipsychotic that effects dopamine and serotonin receptors in the brain and is used for the treatment of schizophrenia. In 2009, the FDA determined that sertindole was effective in the treatment of schizophrenia but considered unsafe based on findings showing increased risks for cardiac anomalies, weight gain, rhinitis, and problems with sexual functioning compared to haloperidol. PMID: 16034864. As of October 2010, sertindole has not been approved for use in the United States by the FDA. Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Sertindole
- Part Display Name
- Sertindole
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2018-03-27
- Construct for LOINC Short Name
- Sertindole
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP266723-8 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP266723-8
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| it-IT | Italian (Italy) | Sertindolo |
| zh-CN | Chinese (China) | 舍吲哚 Synonyms: CAS 106516-24-9; |
| es-ES | Spanish (Spain) | Sertindol |
| nl-NL | Dutch (Netherlands) | sertindol |
| el-GR | Greek (Greece) | Σερτινδόλη Synonyms: Σερτινδόλη |
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://